| Schedule of revenue recognition |
| |
|
Three
Months Ended June 30, |
|
| |
|
2020 |
|
|
2019 |
|
| Products: |
|
|
|
|
|
|
| Disposable
products: |
|
|
|
|
|
|
|
|
| Functional
neurosurgery |
|
$ |
1,049,015 |
|
|
$ |
1,690,122 |
|
| Biologics
and drug delivery |
|
|
406,955 |
|
|
|
244,949 |
|
| Therapy |
|
|
21,300 |
|
|
|
17,830 |
|
| Capital
equipment |
|
|
115,800 |
|
|
|
241,293 |
|
| Total
product revenue |
|
|
1,593,070 |
|
|
|
2,194,194 |
|
| Services: |
|
|
|
|
|
|
|
|
| Capital
equipment and other |
|
|
123,998 |
|
|
|
243,954 |
|
| Biologics
and drug delivery |
|
|
760,714 |
|
|
|
168,250 |
|
| Total
service revenue |
|
|
884,712 |
|
|
|
412,204 |
|
| Total
revenue |
|
$ |
2,477,782 |
|
|
$ |
2,606,398 |
|
| |
|
Six Months Ended June 30, |
|
| |
|
2020 |
|
|
2019 |
|
| Products: |
|
|
|
|
|
|
|
|
| Disposable products: |
|
|
|
|
|
|
|
|
| Functional neurosurgery |
|
$ |
2,733,424 |
|
|
$ |
3,294,767 |
|
| Biologics and drug delivery |
|
|
580,330 |
|
|
|
529,859 |
|
| Therapy |
|
|
78,800 |
|
|
|
17,830 |
|
| Capital equipment |
|
|
303,901 |
|
|
|
515,692 |
|
| Total product revenue |
|
|
3,696,455 |
|
|
|
4,358,148 |
|
| Services: |
|
|
|
|
|
|
|
|
| Capital equipment and other |
|
|
280,493 |
|
|
|
455,156 |
|
| Biologics and drug delivery |
|
|
1,616,428 |
|
|
|
265,611 |
|
| Total service revenue |
|
|
1,896,121 |
|
|
|
720,767 |
|
| Total revenue |
|
$ |
5,593,376 |
|
|
$ |
5,078,915 |
|
|